Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

Cryopreserved Skin - Cryoskin

Swansea Bay University Health Board

This public procurement record has 2 releases in its history.

AwardUpdate

02 Sep 2026 at 15:44

UK5 - Transparency Notice
Award

02 Sep 2026 at 14:16

UK5 - Transparency Notice
Summary of the contracting process

Swansea Bay University Health Board procured cryopreserved human skin allografts, branded Cryoskin, for the Burns Centre’s treatment of burn injuries. The requirement covers the supply, storage and delivery of clinically approved products. Cryoskin is used as temporary wound coverage to promote healing, reduce pain and minimise infection risk for burn patients. NHS Wales is the procuring entity, with Swansea Bay University Health Board as the buyer. This is a specialist medical consumables supply requirement serving tertiary burns care. The work is therefore relevant to tissue-allograft manufacturers, specialist medical suppliers and distributors with the ability to manage regulated human tissue products and dependable delivery into a clinical environment. The procurement comprised one completed lot.

The procurement has reached the awarded and complete stage following a below-threshold direct award without competition. Hospital Innovations Limited was selected as supplier for the single lot. The award value is £227,923.29 excluding VAT, or £273,507.95 including VAT. The award was recorded on 2 September 2026. The contract period runs from 3 September 2026 to 30 June 2029, with signature scheduled for 3 September 2026. The award record is marked pending, while the tender and lot are marked complete. The procurement was evaluated through the direct-award route rather than competitive tendering. The lot was identified as suitable for small and medium-sized enterprises. The award included a subsequent amendment relating to contract value.

This award demonstrates established NHS demand for cryopreserved skin allografts to support specialist burns treatment. A credible future supplier would need proven experience supplying human tissue allografts and the operational capacity to provide consistent, reliable supply to a tertiary Burns Centre. Capability in storage and controlled delivery of clinically approved products would be central, alongside compliance with relevant regulatory, safety and quality standards. Suppliers would also need to work within clinical governance arrangements and understand the specialised requirements of burn-injury care. The opportunity is suitable for an SME, as shown by the buyer’s lot-level suitability assessment. Businesses in this market can use the requirement as a clear reference point for the product, service model and specialist assurance expected by Swansea Bay University Health Board.

How relevant is this notice?

Notice Information

Notice Title

Cryopreserved Skin - Cryoskin

Notice Description

The supply of allograft Cryoskin for use in the treatment of burn injuries within the Burns Centre. The allograft Cryoskin will be required to support clinical care by providing temporary wound coverage to promote healing, reduce pain, and minimise infection risk in patients with burns. The contract will cover the provision, storage, and delivery of clinically approved allograft Cryoskin products in line with relevant regulatory, safety, and quality standards. Suppliers must demonstrate proven experience in the supply of human tissue allografts and the ability to meet the specialised needs of a tertiary Burns Centre, including reliability of supply and adherence to clinical governance requirements.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-06f06c
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/083154-2026
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
UK5 - Transparency Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Direct
Procurement Method Details
Below threshold - without competition
Tender Suitability
SME
Awardee Scale
SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33140000 - Medical consumables

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
£227,923 £100K-£500K
Contracts Value
Not specified

Notice Dates

Publication Date
2 Sep 20261 weeks ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
Not specified
Contract Period
3 Sep 2026 - 30 Jun 2029 2-3 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Pending
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
Swansea Bay University Health Board
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
BAGLAN/PORT TALBOT
Postcode
SA12 7BR
Postcode Area
Swansea
Country
Wales
Major Region (ITL 1)
TLL Wales
Basic Region (ITL 2)
TLL4 Mid and South West Wales
Small Region (ITL 3)
TLL44 Neath Port Talbot
Delivery Location
Not specified
Local Authority
Neath Port Talbot
Electoral Ward
Baglan
Westminster Constituency
Aberafan Maesteg

Supplier Information

Number of Suppliers
1
Supplier Name

Hospital Innovations

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...